A noninvasive method for assessing PNST tumor risk in patients with NF1

NCI Center for Cancer Research shared a post on LinkedIn:

“Featured by National Institutes of Health (NIH): Intramural Research Program (IRP): Neurofibromatosis type 1 (NF1) is a genetic disorder of deregulated cell growth. People with NF1 are at an increased risk of developing a variety of tumors, including peripheral nerve sheath tumors (PNSTs), which can grow along nerves and be malignant.

A team of researchers from CCR’s Pediatric Oncology Branch, alongside extramural collaborators, have developed a noninvasive method for assessing PNST tumor risk in patients with NF1.

Read more.

Image description: ‘The inherited condition neurofibromatosis type 1 is caused by changes in a gene called NF1, which is found on chromosome 17. Credit: DermNetNZ CC BY-NC-ND 3.0 NZ’. ”

Source: NCI Center for Cancer Research/LinkedIn